查詢結果分析
來源資料
相關文獻
- 廣告類中藥製劑之品質調查--補腎、保肝及壯筋骨類
- 廣告類中藥製劑之品質調查--保肝、補腎滋養類
- 廣告類中藥製劑之品質調查--補腎類
- 廣告類中藥製劑之品質調查--補心、減肥類
- 廣告類中藥製劑之品質調查--調經補血類
- 利用毛細管電泳定量中藥製劑成分(3)
- Solid-phase Extraction and High-performance Liquid Chromatographic Analysis of Prednisone Adulterated in a Foreign Herbal Medicine
- 豐田式汽車初期品質管理模式建構之研究--國瑞汽車CORONA PREMIO 1.6&2.0為例
- 臺灣市售防己、牛膝類藥材及含其製劑之研究
- 數種市售健康食品之品質調查研究
頁籤選單縮合
| 題 名 | 廣告類中藥製劑之品質調查--補腎、保肝及壯筋骨類=Investigation on the Quality of Commercial Chinese Herbal Preparations--Liver and Kidney Supplement and Skeleton-Strengthing Formula |
|---|---|
| 作 者 | 秦玲; 曾人和; 林秀珍; 盧芬鈴; 林雅姿; 張華軒; 鄭淑晶; 黃秋羽; 黃成禹; 林哲輝; | 書刊名 | 藥物食品檢驗局調查研究年報 |
| 卷 期 | 24 民95.12 |
| 頁 次 | 頁137-142 |
| 分類號 | 412.36 |
| 關鍵詞 | 中藥製劑; 保肝類; 補腎類; 壯筋骨類; 品質調查; Chinese herbal preparations; Liver and kidney supplement; Skeleton-strengthing formula; Survey; |
| 語 文 | 中文(Chinese) |
| 中文摘要 | 本品質調查之檢體係於民國九十四年二月至八月間由各縣市衛生局抽查所得之65件檢體,依各產品原查驗登記規格與方法包括:外觀、平均重量、重量差異、崩散度、乾燥減重、總灰分、酸不溶性灰分、成分比對等予以檢驗及標示之檢查。檢驗結果,65件檢體中有7件不符規定,佔10.8%,其中平均重量及總灰分不符者各3件(4.6%),外觀、重量差異及酸不溶性灰分不符者各2件(3.1%)。檢體65件分屬46家藥廠,包括18家GMP藥廠、28家非GMP藥廠,而檢驗不符規定之檢體,分屬6家藥廠,其中5家為非GMP藥廠。上述檢驗結果,均逐案函覆原送地方衛生機關依法處理。 |
| 英文摘要 | This study analyzed 65 samples taken from Feb. 2005 to Aug. 2005 by region health authorities , based on the registered specifications and testing methods:appearance, average weight, weight variation, disintegration, dry loss, total ash, acid-insoluble ash, identification and labeling. The results showed that three samples (4.6%) failed to meet the requirements of average weight and total ash determination. Two samples (3.1%) failed to meet the appearance,weight variation and acid-insoluble ash requirement. The samples were manufactured by 46 pharmaceutical plants,including 18 GMP and 28 non-GMP plants. The 7 samples that did not comply with the requirements were manufactured by 6 different pharmaceutical factories, 5 of these are not GMP compliant. |
本系統中英文摘要資訊取自各篇刊載內容。